Teladoc Health (NYSE:TDOC) PT Lowered to $17.00

Teladoc Health (NYSE:TDOC) had its price objective decreased by Oppenheimer from $21.00 to $17.00 in a research note published on Thursday morning, Benzinga reports. Oppenheimer currently has an outperform rating on the health services provider’s stock.

Several other brokerages also recently commented on TDOC. Royal Bank of Canada dropped their price objective on Teladoc Health from $25.00 to $18.00 and set an outperform rating on the stock in a research note on Friday, April 26th. Wells Fargo & Company lowered their price target on shares of Teladoc Health from $17.00 to $15.00 and set an equal weight rating on the stock in a report on Monday, April 29th. JPMorgan Chase & Co. decreased their target price on shares of Teladoc Health from $19.00 to $16.00 and set a neutral rating on the stock in a research report on Tuesday, May 21st. Bank of America reduced their price target on Teladoc Health from $16.50 to $13.50 and set a neutral rating on the stock in a research report on Tuesday, May 14th. Finally, Canaccord Genuity Group lowered their price target on Teladoc Health from $28.00 to $25.00 and set a buy rating for the company in a research report on Friday, April 26th. Fourteen investment analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of Hold and an average target price of $14.44.

Teladoc Health Stock Down 3.1 %

Shares of TDOC stock traded down $0.25 on Thursday, reaching $7.70. 4,184,381 shares of the company’s stock traded hands, compared to its average volume of 5,454,640. The business’s 50 day moving average price is $9.88 and its two-hundred day moving average price is $13.61. The company has a debt-to-equity ratio of 0.67, a quick ratio of 3.74 and a current ratio of 3.82. The company has a market capitalization of $1.31 billion, a P/E ratio of -5.64 and a beta of 0.93. Teladoc Health has a 12-month low of $7.31 and a 12-month high of $26.00.

Insider Transactions at Teladoc Health

In related news, Director Karen L. Daniel sold 9,834 shares of Teladoc Health stock in a transaction that occurred on Thursday, May 23rd. The stock was sold at an average price of $11.90, for a total value of $117,024.60. Following the sale, the director now owns 36,995 shares of the company’s stock, valued at approximately $440,240.50. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Over the last three months, insiders have sold 15,388 shares of company stock worth $178,225. Corporate insiders own 0.95% of the company’s stock.

Institutional Investors Weigh In On Teladoc Health

A number of large investors have recently bought and sold shares of TDOC. ICA Group Wealth Management LLC purchased a new stake in Teladoc Health during the 4th quarter worth about $28,000. Signaturefd LLC grew its holdings in shares of Teladoc Health by 148.7% during the 2nd quarter. Signaturefd LLC now owns 2,868 shares of the health services provider’s stock worth $28,000 after acquiring an additional 1,715 shares during the period. International Assets Investment Management LLC purchased a new stake in Teladoc Health in the second quarter worth about $29,000. Hexagon Capital Partners LLC increased its stake in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock valued at $34,000 after purchasing an additional 1,065 shares in the last quarter. Finally, RIA Advisory Group LLC purchased a new stake in Teladoc Health during the 4th quarter valued at $36,000. 76.82% of the stock is currently owned by institutional investors and hedge funds.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.